Question 1

Does Connor, Clark & Lunn Investment Management own NAGE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Connor, Clark & Lunn Investment Management holds 458,614 shares of NAGE (Niagen Bioscience), worth $1.5M.

Question 2

How many shares of NAGE does Connor, Clark & Lunn Investment Management own?

Accepted Answer

As of its Q2 2026 13F, Connor, Clark & Lunn Investment Management holds 458,614 shares of NAGE (Niagen Bioscience).

Question 3

What is Connor, Clark & Lunn Investment Management's NAGE position worth?

Accepted Answer

As of its Q2 2026 13F, Connor, Clark & Lunn Investment Management's NAGE position is worth $1.5M.

Question 4

Is Connor, Clark & Lunn Investment Management buying or selling NAGE?

Accepted Answer

In Q2 2026, Connor, Clark & Lunn Investment Management reduced its NAGE position by 123,834 shares (-21.3%).

Question 5

When did Connor, Clark & Lunn Investment Management first buy NAGE?

Accepted Answer

Connor, Clark & Lunn Investment Management first reported NAGE in its Q2 2023 13F and has listed it in 13 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	458,614	-21.3%	$1.5M	0.0%	$3.19	0
2026-Q1	Decreased	582,448	-0.3%	$2.6M	0.0%	$4.41	0
2025-Q4	Decreased	584,229	-7.0%	$3.7M	0.0%	$6.36	0
2025-Q3	Decreased	627,879	-23.7%	$5.9M	0.0%	$9.33	0
2025-Q2	Increased	823,325	+10.6%	$11.9M	0.0%	$14.41	31
2025-Q1	Increased	744,490	+47.1%	$5.1M	0.0%	$6.90	37
2024-Q4	Increased	506,186	+189.0%	$2.7M	0.0%	$5.31	42
2024-Q3	Increased	175,172	+10.8%	$639,378	0.0%	$3.65	27
2024-Q2	Increased	158,057	+18.8%	$431,496	0.0%	$2.73	28
2024-Q1	Increased	133,066	+14.2%	$463,070	0.0%	$3.48	27
2023-Q4	Increased	116,513	+40.3%	$166,614	0.0%	$1.43	30
2023-Q3	Increased	83,031	+121.9%	$121,225	0.0%	$1.46	36
2023-Q2	New	37,413	-	$58,738	0.0%	$1.57	29

NAGE13 quarters

NAGE
13 quarters